scholarly journals Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous iron

2018 ◽  
Vol Volume 9 ◽  
pp. 285-298 ◽  
Author(s):  
William Strauss ◽  
Michael Auerbach
2006 ◽  
Vol 15 (10) ◽  
pp. 1559-1563 ◽  
Author(s):  
Kiyoshi Ando ◽  
Satoshi Morita ◽  
Takahiro Higashi ◽  
Shunichi Fukuhara ◽  
Shigeki Watanabe ◽  
...  

2018 ◽  
Vol 41 (1) ◽  
pp. 22-29
Author(s):  
Carlos González Alayón ◽  
Carolina Pedrajas Crespo ◽  
Sandra Marín Pedrosa ◽  
José Manuel Benítez ◽  
Eva Iglesias Flores ◽  
...  

2013 ◽  
Vol 15 (10) ◽  
pp. 1164-1172 ◽  
Author(s):  
Josep Comín-Colet ◽  
Cristina Enjuanes ◽  
Gina González ◽  
Ainhoa Torrens ◽  
Mercè Cladellas ◽  
...  

2020 ◽  
Vol 2 (3) ◽  
Author(s):  
Christopher L Coe ◽  
Matthew H Meyers ◽  
Dawn B Beaulieu ◽  
Elizabeth Scoville ◽  
David A Schwartz ◽  
...  

Abstract Background The effectiveness and safety of gastroenterologist (GI)-lead treatment of iron deficiency anemia (IDA) in inflammatory bowel disease (IBD) have not been well-studied. Methods A retrospective chart review of patients with IBD, IDA, and evidence of treatment with iron at a tertiary IBD center was conducted. Results In 351 patients, hemoglobin and quality of life scores increased significantly after treatment with iron. Twelve of 341 patients treated with intravenous iron had an adverse effect. Twenty-seven patients required a hematology referral. Conclusion GIs should consider treating patients with IBD and IDA with intravenous iron as it is safe and effective.


Sign in / Sign up

Export Citation Format

Share Document